The Minister of Health, Aden Duale, has announced the first 15 counties to receive Lenacapavir, the HIV Prevention Injection, ...

South Africa will launch Lenacapavir, a six-month HIV prevention injection, in six provinces, targeting all HIV-negative ...

Kenya has received 21,000 doses of the long-acting HIV prevention injection Lenacapavir, with rollout set to begin in March.

Kenya is one of nine African countries selected for the initial rollout of lenacapavir (LEN), a new injectable drug for human immunodeficiency virus (HIV) prevention, scheduled for January 2026.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced details of new clinical and real-world data from its innovative HIV treatment and prevention portfolio and research pipeline that will be presented ...

NAIROBI, Feb. 18 (Xinhua) -- Kenya's Ministry of Health has received an initial consignment of 21,000 starter doses of Lenacapavir, a twice-yearly injectable drug for HIV prevention.

The Food and Drug Administration (FDA) recently approved lenacapavir for HIV prevention in both men and women. Many experts believe this twice a year treatment could be a game changer in the fight ...

The approval of lenacapavir for use as pre-exposure prophylaxis is a significant step in reducing the incidence of HIV across the globe, including in areas where the PURPOSE trials were conducted. If ...

Kenya received its first batch of 21,000 doses on Tuesday through a deal with lenacapavir's manufacturer, Gilead Sciences, and the Global Fund to Fight AIDS. "The first phase of implementation will ...

A newly approved drug gives almost total protection against getting HIV. The FDA approved lenacapavir last week. Patients need just two injections of it a year to get that protection, but as NPR's ...

Please provide your email address to receive an email when new articles are posted on . Many real-world patients added lenacapavir while already suppressed. More than half of patients simplified ...

Kenya has received an initial consignment of 21,000 starter doses of the long-acting injectable HIV prevention drug Lenacapavir, marking the first phase of a nationwide rollout set to begin in March ...